- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
July 30th, 2007
Biocon Ltd, India's leading biotechnology firm, has entered into an agreement with Neopharma, a leading Abu Dhabi-based pharma company owned by an Indian, to set up a joint venture (JV) in Dubai's biotech and research park - Dubaitech.
The new venture, christened Neobiocon, will manufacture and market bio-therapeutics in the Gulf region and fulfil the vision of the UAE's former president, late Sheikh Zayed Al Nahyan, to provide 'health for all' at affordable price, according to a company statement here Monday.
Neopharma plans to foray into European markets and work on nanotechnology-based products. Its facility is recognised as a regional contract manufacturing hub for European and Canadian firms.
|Related News Press|
Fighting cancer with sticky nanoparticles September 27th, 2016
Cambrios at CEATEC - Japan 2016 September 29th, 2016
Synopsys Joins GLOBALFOUNDRIES’ FDXcelerator Partner Program to Enable Innovative Designs Using the FD-SOI Process: Program Gives Synopsys Access to GLOBALFOUNDRIES’ FDX Portfolio and Provides Customers with Tools that Support the Differentiated Features of FD-SOI September 8th, 2016